During the past decade, East Carolina Gastroenterology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "East Carolina Gastroenterology" #1 sponsor was "Bausch Health Americas, Inc." with 4 trials, followed by "Shire" with 4 trials sponsored, "Celgene" with 2 trials sponsored, "Ironwood Pharmaceuticals, Inc." with 1 trials sponsored and "Phathom Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "East Carolina Gastroenterology" are "Ulcerative Colitis" (8 trials), "Inflammatory Bowel Disease" (2 trials), "Irritable Bowel Syndrome" (2 trials), "Celiac Disease" (1 trials) and "Clostridium Infections" (1 trials). Many other conditions were trialed in "East Carolina Gastroenterology" in a lesser frequency.

Most popular intervention types in "East Carolina Gastroenterology" are "Drug" (14 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Ontamalimab" (2 trials), "RPC1063" (2 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "East Carolina Gastroenterology" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "East Carolina Gastroenterology". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in East Carolina Gastroenterology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in East Carolina Gastroenterology, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".